Skip to main content
Top
Published in: Tumor Biology 4/2014

01-04-2014 | Research Article

Differential expression profiling of microRNAs and their potential involvement in esophageal squamous cell carcinoma

Authors: Wenqiao Zang, Yuanyuan Wang, Yuwen Du, Xiaoyan Xuan, Tao Wang, Min Li, Yunyun Ma, Ping Li, Xudong Chen, Ziming Dong, Guoqiang Zhao

Published in: Tumor Biology | Issue 4/2014

Login to get access

Abstract

MicroRNAs are small, noncoding RNAs approximately 18–24 nucleotides in length that negatively regulate gene expression at the posttranscriptional and/or translational level by binding to complimentary sequences in the 3′-untranslated regions of target mRNAs. Growing evidence has indicated the important roles for different miRNA species in the development of different cancers. Therefore, miRNAs have the potential to become new biological markers for esophageal squamous cell carcinoma (ESCC) and to be applied in the diagnosis, prognosis, and targeted treatment of ESCC. In this study, we performed a miRNA microarray to analyze the miRNA expression profile in ESCC compared to normal tissues. Then, we made a preliminary analysis of the biological function for the most differentially expressed miRNAs and their potentially target genes regulated. Some microarray results were validated by performing quantitative RT-PCR. The study provided evidence that linked the biological role of miRNAs to ESCC and showed that miRNAs could undertake a variety of mechanisms. Additionally, we also found that altered miR-429 and miR-451 expression levels were associated with the occurrence of lymph node metastases and the differentiation status and TNM stage in ESCC. The study of miRNAs may lead to finding novel methods to diagnose, treat, and prevent ESCC.
Literature
3.
go back to reference Hsu PK, Huang CS, Wang BY, Wu YC, Chou TY, Hsu WH. The prognostic value of the number of negative lymph nodes in esophageal cancer patients after transthoracic resection. Ann Thorac Surg. 2013;96(3):995–1001.PubMedCrossRef Hsu PK, Huang CS, Wang BY, Wu YC, Chou TY, Hsu WH. The prognostic value of the number of negative lymph nodes in esophageal cancer patients after transthoracic resection. Ann Thorac Surg. 2013;96(3):995–1001.PubMedCrossRef
4.
go back to reference Esquela-Kerscher A, Slack FJ. Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer. 2006;6:259–69.PubMedCrossRef Esquela-Kerscher A, Slack FJ. Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer. 2006;6:259–69.PubMedCrossRef
5.
6.
go back to reference Tsang J, Zhu J, van Oudenaarden A. MicroRNA-mediated feedback and feedforward loops are recurrent network motifs in mammals. Mol Cell. 2007;26:753–67.PubMedCentralPubMedCrossRef Tsang J, Zhu J, van Oudenaarden A. MicroRNA-mediated feedback and feedforward loops are recurrent network motifs in mammals. Mol Cell. 2007;26:753–67.PubMedCentralPubMedCrossRef
9.
go back to reference Kren BT, Wong PY, Sarver A, Zhang X, Zeng Y, Steer CJ. MicroRNAs identified in highly purified liver-derived mitochondria may play a role in apoptosis. RNA Biol. 2009;6:65–72.PubMedCentralPubMedCrossRef Kren BT, Wong PY, Sarver A, Zhang X, Zeng Y, Steer CJ. MicroRNAs identified in highly purified liver-derived mitochondria may play a role in apoptosis. RNA Biol. 2009;6:65–72.PubMedCentralPubMedCrossRef
10.
go back to reference Bian Z, Li LM, Tang R, Hou DX, Chen X, Zhang CY, et al. Identification of mouse liver mitochondria-associated miRNAs and their potential biological functions. Cell Res. 2010;20:1076–8.PubMedCrossRef Bian Z, Li LM, Tang R, Hou DX, Chen X, Zhang CY, et al. Identification of mouse liver mitochondria-associated miRNAs and their potential biological functions. Cell Res. 2010;20:1076–8.PubMedCrossRef
12.
go back to reference Cairns RA, Harris I, McCracken S, Mak TW. Cancer cell metabolism. Cold Spring Harb Symp Quant Biol. 2011;76:299–311.PubMedCrossRef Cairns RA, Harris I, McCracken S, Mak TW. Cancer cell metabolism. Cold Spring Harb Symp Quant Biol. 2011;76:299–311.PubMedCrossRef
13.
go back to reference Thomson JM, Parker J, Perou CM, Hammond SM. A custom microarray platform for analysis of microRNA gene expression. Nat Methods. 2004;1:47–53.PubMedCrossRef Thomson JM, Parker J, Perou CM, Hammond SM. A custom microarray platform for analysis of microRNA gene expression. Nat Methods. 2004;1:47–53.PubMedCrossRef
14.
go back to reference Nelson PT, Baldwin DA, Scearce LM, Oberholtzer JC, Tobias JW, Mourelatos Z. Microarray-based, high through put gene expression profiling of microRNAs. Nat Methods. 2004;1:155–61.PubMedCrossRef Nelson PT, Baldwin DA, Scearce LM, Oberholtzer JC, Tobias JW, Mourelatos Z. Microarray-based, high through put gene expression profiling of microRNAs. Nat Methods. 2004;1:155–61.PubMedCrossRef
15.
go back to reference Barad O, Meiri E, Avniel A, Aharonov R, Barzilai A, Bentwich I, et al. MicroRNA expression detected by oligo nucleotide microarrays: system establishment and expression profiling in human tissues. Genome Res. 2004;14:2486–94.PubMedCentralPubMedCrossRef Barad O, Meiri E, Avniel A, Aharonov R, Barzilai A, Bentwich I, et al. MicroRNA expression detected by oligo nucleotide microarrays: system establishment and expression profiling in human tissues. Genome Res. 2004;14:2486–94.PubMedCentralPubMedCrossRef
16.
go back to reference Babak T, Zhang W, Morris Q, Blencowe BJ, Hughes TR. Probing microRNAs with microarrays: tissue specificity and functional inference. RNA. 2004;10:1813–9.PubMedCentralPubMedCrossRef Babak T, Zhang W, Morris Q, Blencowe BJ, Hughes TR. Probing microRNAs with microarrays: tissue specificity and functional inference. RNA. 2004;10:1813–9.PubMedCentralPubMedCrossRef
17.
go back to reference Shingara J, Keiger K, Shelton J, Laosinchai-Wolf W, Powers P, Conrad R, et al. An optimized isolation and labeling platform for accurate microRNA expression profiling. RNA. 2005;11:1461–70.PubMedCentralPubMedCrossRef Shingara J, Keiger K, Shelton J, Laosinchai-Wolf W, Powers P, Conrad R, et al. An optimized isolation and labeling platform for accurate microRNA expression profiling. RNA. 2005;11:1461–70.PubMedCentralPubMedCrossRef
18.
go back to reference Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834–8.PubMedCrossRef Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834–8.PubMedCrossRef
19.
go back to reference Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005;33:e179.PubMedCentralPubMedCrossRef Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005;33:e179.PubMedCentralPubMedCrossRef
20.
go back to reference Nagadia R, Pandit P, Coman WB, Cooper-White J, Punyadeera C. miRNAs in head and neck cancer revisited. Cell Oncol. 2013;36(1):1–7.CrossRef Nagadia R, Pandit P, Coman WB, Cooper-White J, Punyadeera C. miRNAs in head and neck cancer revisited. Cell Oncol. 2013;36(1):1–7.CrossRef
21.
go back to reference Wang Y, Li M, Zang W, Ma Y, Wang N, Li P, et al. MiR-429 up-regulation induces apoptosis and suppresses invasion by targeting Bcl-2 and SP-1 in esophageal carcinoma. Cell Oncol (Dordr). 2013;36(5):385–94.CrossRef Wang Y, Li M, Zang W, Ma Y, Wang N, Li P, et al. MiR-429 up-regulation induces apoptosis and suppresses invasion by targeting Bcl-2 and SP-1 in esophageal carcinoma. Cell Oncol (Dordr). 2013;36(5):385–94.CrossRef
22.
go back to reference Wang T, Zang WQ, Li M, Wang N, Zheng YL, Zhao GQ. Effect of miR-451 on the biological behavior of the esophageal carcinoma cell line EC9706. Dig Dis Sci. 2013;58(3):706–14.PubMedCrossRef Wang T, Zang WQ, Li M, Wang N, Zheng YL, Zhao GQ. Effect of miR-451 on the biological behavior of the esophageal carcinoma cell line EC9706. Dig Dis Sci. 2013;58(3):706–14.PubMedCrossRef
23.
go back to reference Hu YC, Lam KY, Law S, Wong J, Srivastava G. Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by cDNA expression array: overexpression of Fra-1, Neogenin, Id-1, and CDC25B genes in ESCC. Clin Cancer Res. 2001;7:2213–21.PubMed Hu YC, Lam KY, Law S, Wong J, Srivastava G. Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by cDNA expression array: overexpression of Fra-1, Neogenin, Id-1, and CDC25B genes in ESCC. Clin Cancer Res. 2001;7:2213–21.PubMed
24.
go back to reference Li Y, Chen L, Nie CJ, Zeng TT, Liu H, Mao X, et al. Downregulation of RBMS3 is associated with poor prognosis in esophageal squamous cell carcinoma. Cancer Res. 2011;19:6106–15. Dig Dis Sci. 2013 ;58(3):706–14.CrossRef Li Y, Chen L, Nie CJ, Zeng TT, Liu H, Mao X, et al. Downregulation of RBMS3 is associated with poor prognosis in esophageal squamous cell carcinoma. Cancer Res. 2011;19:6106–15. Dig Dis Sci. 2013 ;58(3):706–14.CrossRef
25.
26.
go back to reference Feber A, Xi L, Luketich JD, Pennathur A, Landreneau RJ, Wu M, et al. MicroRNA expression profiles of esophageal cancer. J Thorac Cardiovasc Surg. 2008;135:255–60.PubMedCentralPubMedCrossRef Feber A, Xi L, Luketich JD, Pennathur A, Landreneau RJ, Wu M, et al. MicroRNA expression profiles of esophageal cancer. J Thorac Cardiovasc Surg. 2008;135:255–60.PubMedCentralPubMedCrossRef
27.
go back to reference Zhang C, Wang C, Chen X, Yang C, Li K, Wang J, et al. Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma. Clin Chem. 2010;56:1871–9.PubMedCrossRef Zhang C, Wang C, Chen X, Yang C, Li K, Wang J, et al. Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma. Clin Chem. 2010;56:1871–9.PubMedCrossRef
28.
go back to reference Zhuang, Wu X, Jiang Z, Kasman I, Yao J, Guan Y, et al. Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK–STAT pathway. EMBO J. 2012;31:3513–23.PubMedCentralPubMedCrossRef Zhuang, Wu X, Jiang Z, Kasman I, Yao J, Guan Y, et al. Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK–STAT pathway. EMBO J. 2012;31:3513–23.PubMedCentralPubMedCrossRef
30.
go back to reference Gibbings DJ, Ciaudo C, Erhardt M, Voinnet O. Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat Cell Biol. 2009;11:1143–9.PubMedCrossRef Gibbings DJ, Ciaudo C, Erhardt M, Voinnet O. Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat Cell Biol. 2009;11:1143–9.PubMedCrossRef
32.
go back to reference Das S, Ferlito M, Kent OA, Fox-Talbot K, Wang R, Liu D, et al. Steenbergen, Nuclear miRNA regulates the mitochondrial genome in the heart. Circ Res. 2012;110:1596–603.PubMedCentralPubMedCrossRef Das S, Ferlito M, Kent OA, Fox-Talbot K, Wang R, Liu D, et al. Steenbergen, Nuclear miRNA regulates the mitochondrial genome in the heart. Circ Res. 2012;110:1596–603.PubMedCentralPubMedCrossRef
Metadata
Title
Differential expression profiling of microRNAs and their potential involvement in esophageal squamous cell carcinoma
Authors
Wenqiao Zang
Yuanyuan Wang
Yuwen Du
Xiaoyan Xuan
Tao Wang
Min Li
Yunyun Ma
Ping Li
Xudong Chen
Ziming Dong
Guoqiang Zhao
Publication date
01-04-2014
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 4/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-013-1432-5

Other articles of this Issue 4/2014

Tumor Biology 4/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine